Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Modell et al found that only half the couples at risk of having
a child with thalassaemia received a service that allowed them an
informed choice in genetic screening for the condition, with wide
variation by region and ethnic group.1 For informed choice
to be translated into the practical reality of a prenatal diagnostic
procedure, haemoglobinopathy screening needs to be undertaken in the
first trimester.
In general practice the window of opportunity is small, as many mothers do not present for confirmation of pregnancy until after their second missed period. Even with early electrophoresis, if the woman is found to be a carrier it is necessary then to find her partner and persuade him to come for testing.
To overcome these time constraints, the practice where I work
offers all men and women haemoglobinopathy screening based on their
self perception of risk. Screening is undertaken at a registration
Read all Rapid Responses